Article Information
History
- November 15, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Steven N. Hart1,*,
- Eric C. Polley1,
- Amal Yussuf4,
- Siddhartha Yadav2,
- David E. Goldgar3,
- Chunling Hu5,
- Holly LaDuca4,
- Laura P. Smith4,
- June Fujimoto4,
- Shuwei Li4,
- Fergus J. Couch5 and
- Jill S. Dolinsky4,*
- 1Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
- 2Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA
- 3Department of Dermatology, University of Utah, Salt Lake City, Utah, USA
- 4Ambry Genetics, Aliso Viejo, California, USA
- 5Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
- ↵*Correspondence: Jill S. Dolinsky, MS, CGC jdolinsky{at}ambrygen.com, Hart, Steven N., Ph.D. Hart.Steven{at}mayo.edu
Posted November 15, 2019.
Mutation prevalence tables for hereditary cancer derived from multi-gene panel testing
